Skip to main content

SOCIETY FOR VASCULAR SURGERY FOUNDATION

EIN: 04-3580038Rosemont, ILZIP: 60018
G43 - Diseases, Disorders & Medical Disciplines501(c)(3)

Mission

TO PERFORM AND CARRY OUT SUCH EDUCATIONAL, SCIENTIFIC AND CHARITABLE FUNCTIONS AND PURPOSES OF THE SOCIETY FOR VASCULAR SURGERY (SVS) AS MAY BE DELEGATED TO THE FOUNDATION.

Financials

YearRevenueExpensesAssets
2023$1.3M$0$7.8M
2022$998k$0$7.4M

Compensation

2023

BERNADETTE AULIVOLA MD
$0
$0
$0
$0
MATTHEW J EAGLETON MD
$0
$0
$0
$0
THOMAS L FORBES MD
$0
$0
$0
$0
MICHAEL C DALSING MD
$0
$0
$0
$0
RAUL J GUZMAN MD
$0
$0
$0
$0
VIKRAM S KASHYAP MD
$0
$0
$0
$0
JOSEPH L MILLS MD
$0
$0
$0
$0
ANIL P HINGORANI MD
$0
$0
$0
$0
ULKA SACHDEV-OST MD FACS
$0
$0
$0
$0
PETER R NELSON MD MS
$0
$0
$0
$0
GEETHA JEYABALAN MD
$0
$0
$0
$0

2022

KEITH D CALLIGARO MD
$0
$0
$0
$0
MICHAEL C DALSING MD
$0
$0
$0
$0
RAUL J GUZMAN MD
$0
$0
$0
$0
JOSEPH P HART MD MHL FACS
$0
$0
$0
$0
NASIM HEDAYATI MD MS
$0
$0
$0
$0
ANIL HINGORANI MD
$0
$0
$0
$0
ULKA SACHDEV MD FACS
$0
$0
$0
$0
GEETHA JAYABALAN MD
$0
$0
$0
$0
PETER F LAWRENCE
$0
$0
$0
$0

Similar Organizations

Similar sector (G)Very similar revenue ($1.2M vs $1.3M)Same state (Illinois)
$1.4M revenue
Similar sector (G)Very similar revenue ($1.4M vs $1.3M)Same state (Illinois)
R O W FOUNDATION

Naperville, IL

$1.2M revenue
Similar sector (G)Very similar revenue ($1.2M vs $1.3M)Same state (Illinois)
$1.3M revenue
Similar sector (G)Very similar revenue ($1.3M vs $1.3M)Same state (Illinois)
Similar sector (G)Very similar revenue ($1.3M vs $1.3M)Same state (Illinois)
Similar sector (G)Very similar revenue ($1.4M vs $1.3M)Same state (Illinois)
$1.5M revenue
Similar sector (G)Very similar revenue ($1.5M vs $1.3M)Same state (Illinois)
$1.4M revenue
Similar sector (G)Very similar revenue ($1.4M vs $1.3M)Same state (Illinois)
$1.5M revenue
Similar sector (G)Very similar revenue ($1.5M vs $1.3M)Same state (Illinois)
$1.6M revenue
Similar sector (G)Similar revenue ($1.6M vs $1.3M)Same state (Illinois)
Data from IRS Form 990 filings (2022-2023).